FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway is a paper indexed in ScholarIQ from OpenAlex.
How many citations does FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway have?
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway has 92 citations in the OpenAlex counts ScholarIQ stores.
When was FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway published?
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway has 2014 year in the ScholarIQ index.
What is the open-access status of FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway?
FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway has closed oa status in the ScholarIQ index.
What is the DOI of FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway?
The DOI for FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway is on the source record.
What is the PMID of FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway?
The PMID for FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway is on the source record.
What is the OpenAlex record for FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway?
The OpenAlex for FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway is on the source record.